New injection combo shows promise against head and neck cancer
Disease control
Recruiting now
This early-phase study tests a new drug, VLPONC-01, injected directly into head and neck tumors to see if it's safe and can shrink tumors. About 41 adults with advanced head and neck cancer will receive the injection alone or with an immunotherapy drug (pembrolizumab). The goal i…
Phase: PHASE1 • Sponsor: VLP Therapeutics • Aim: Disease control
Last updated May 17, 2026 00:48 UTC